Number of people with type 2 diabetes worldwide2,3
Estimated number of obese type 2 diabetes patients who are refractory to oral medication3,4,5
Percentage of type 2 diabetes patients who are obese5
Yearly cost of diabetes treatment globally2
Yearly global expenditure on insulin6
Percentage of insulin users who show symptoms of anxiety and distress from insulin injections7
… While there have been remarkable advancements in recent years, there continue to be deficits in type 2 diabetes therapies. An optimal treatment would meaningfully reduce HbA1c, minimize patient adherence as a factor in treatment efficacy, and have minimal side effects. If this were achieved, the consumption of healthcare resources could be significantly reduced while improving the lives of millions of patients.